Resultados de la búsqueda 461-470 of 24966 for Treatment
Patients may receive a single dose to a liver lobe or segmental treatment delivered as a sequence of treatments approximately 30-90 days apart. The principal ...
... treatment of patients with chronic myelomonocytic leukemia that has come back (recurrent) or that does not respond to treatment (refractory). Onvansertib is ...
But it has a higher risk of some complications and a longer recovery time than other, less invasive treatments for an enlarged prostate. One such treatment is a ...
To describe the clinical features along with treatment outcomes of a cohort of patients with a diagnosis of NMOSD after the latest revised criteria in 2015 by ...
... treatment (refractory). Monoclonal antibodies, such as rituximab, may block ... Giving rituximab together with romidepsin and lenalidomide may be a better ...
Lecanemab approved for treatment of early Alzheimer's disease. Alzheimer's Association. https://www.alz.org/alzheimers-dementia/treatments/lecanemab-leqembi.
Laser treatment of ethnic skin. In: Procedures in Cosmetic Dermatology: Lasers, Lights, and Energy Devices. 5th ed. Elsevier; 2023. https://www.clinicalkey ...
This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same treatment plus ...
... treatment. A Study to Develop Liquid Biopsy for Pediatric Brain Tumor Patients. Rochester, Minn. The purpose of this study is to confirm detection of the ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?